NXP Semiconductors [NXPI] - Last Close: $166.01 NXP Semiconductors is rallying on strong earnings. The microchip manufacturer reported its fiscal Q1 earnings late Monday, and the results topped analyst forecasts. NXP reported quarterly revenues of $3.12 billion and beat the consensus estimate of $3.0 billion. Non-GAAP diluted earnings came in at $3.19 per share, which topped analysts' $3.02 target. NXP's Q2 guidance called for sales ranging between $3.10 billion and $3.30 billion, topping the Street's $3.04 billion target. NXPI is leading the S&P 500 with a 4.9% premarket gain. My Take: NXPI has tracked sideways for most of 2023, but it could be on the verge of a pivot. Volume has spiked over the last three trading session, and share prices could find support at $160 per share. Immatics [IMTX] - Last Close: $7.32 Immatics is moving higher after a clinical update. The clinical-stage biopharma firm reported interim clinical data from an ongoing Phase 1b trial evaluating IMA203 TCR-T monotherapy against PRAME. According to the release, the therapy produced a 67% objective response rate at 3 months in dose expansion Cohort A. Cohort A also continues to show manageable toleribility with no high-grade adverse effects, such as CRS and ICANS. The company said it expects to provide another update and a pathway towards registration-directed trials in Q4 2023. IMTX is up 23.0% on the upbeat clinical data. My Take: IMTX has had a rough year, but it's showing some signs of life over the past two weeks. A new positive trend could be developing, and today's news could help the stock get back on track. AGBA Group [AGBA] - Last Close: $2.02 An upbeat business update is boosting shares of AGBA Group. Yesterday, the Hong Kong-based financial services released a statement regarding its financial expectations for 2023. AGBA says it expects to generate US$160 million in revenues for 2023, equivalent to a 533% year-over-year growth rate. The company said it expects a "new wave of revenue growth in 2023 and 2024" as a result of China's border reopening. Shares are up 12.3% on the heels of the update. My Take: AGBA is part of the broad rally we've seen in China stocks over the past few sessions. Be very cautious about trading AGBA and other no-name, micro-cap China stocks because they can reverse course quickly. Lilium [LILM] - Last Close: $0.3832 Lilium is moving higher after an early morning announcement. The all-electric vertical take-off jet company said it has secured a capital raise for up to $250 million, with $100 million funded at the close. Lilium filed a Form 6-K disclosing the capital raise to the SEC and investors on May 1st. The company says the capital raise will allow it to continue development of its Lilium Jet and help them work towards its first manned flight. LILM is one of today's top movers with a 44.1% gain. My Take: LILM is a Very tiny stock with a very ugly chart and a long-shot business model. With that in mind, there could be some opportunities for brief upswings. GainersHour Loop [HOUR] >> +224.6%Leju Holdings [LEJU] >> +65.4%Huize Holdings [HUIZ] >> +43.7%DeclinersChegg [CHGG] >> (44.0%)GD Culture [GDC] >> (47.7%)Utime [UTME] >> (34.0%) Pfizer, Inc. [PFE] ... AM Illinois Tool Works Inc. [ITW] ... AM Eaton Corporation, Plc [ETN] ... AM Uber Technologies, Inc. [UBER] ... AM Marriott International [MAR] ... AM Ecolab Inc. [ECL] ... AM DuPont [DD] ... AM Idexx Laboratories, Inc. [IDXX] ... AM Advanced Micro Devices Inc [AMD] ... PM Starbucks Corporation [SBUX] ... PM Ford Motor Co Del [F] ... PM Clorox [CLX] ... PM U.S. job openings [Mar] ... 10:00a Factory orders [Mar] ... 10:00a |